Inflammation of white adipose tissue may be a better predictor of breast cancer incomes than body mass index, according to Andrew Dannenberg, M.D. Read more
There has been an overemphasis on the genomic component of precision medicine, according to Mark Rubin, M.D., director of the Englander Institute for Precision Medicine. Read more
Eftychia Apostolou, Ph.D., has won a New Innovator Award from the National Institutes of Health for her research on how cells preserve their identity under normal conditions or alter it during pathogenesis Read more
While chemotherapy kills the most common type of bladder cancer, urothelial cancer, it also shapes the genetic evolution of remaining urothelial cancer cell clones to become drug-resistant, according to Bishoy Faltas and colleagues. Read more
David Rickman, Ph.D., and colleagues have identified a gene that appears to regulate the change from prostate adenocarcinoma to neuroendocrine prostate cancer. Read more
Alisertib monotherapy may be effective in certain patients with clinical or pathologically defined neuroendocrine prostate cancer, according to Himisha Beltran, M.D. Read more
A new collaboration will be formed to help further data analysis for the Cancer Genome Atlas project, thanks to a $490,000 grant from the National Cancer Institute. Read more
A community has rallied around an 8-year-old with pediatric brain cancer, and the doctor who has saved her life so far with his experimental treatment. Read more